Clinical Research: Clinical Trials

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 21-30 of 47 total displayed.

Past content

CCR Focus
Phase 0 Trials: An Industry Perspective

Helen Eliopoulos, Vincent Giranda, Robert Carr, Rita Tiehen, Terri Leahy, and Gary Gordon
Clin. Cancer Res. 2008; 14: 3683-3688. [Abstract] [Full text] [PDF]  

CCR Focus
Patient Perspectives on Phase 0 Clinical Trials

Martin Gutierrez and Deborah Collyar
Clin. Cancer Res. 2008; 14: 3689-3691. [Full text] [PDF]  

CCR Focus
The Ethics of Phase 0 Oncology Trials

Emily Abdoler, Holly Taylor, and David Wendler
Clin. Cancer Res. 2008; 14: 3692-3697. [Abstract] [Full text] [PDF]  

Review
Mammalian target of rapamycin inhibition as a therapeutic strategy in the management of urologic malignancies

Jorge A. Garcia and David Danielpour
Mol. Cancer Ther. 2008; 7: 1347-1354. [Abstract] [Full text] [PDF]  

Reviews
Unraveling the Mystery of Erythropoietin-Stimulating Agents in Cancer Promotion

Kelly A. May and Fadlo R. Khuri
Cancer Res. 2008; 68: 4013-4017. [Abstract] [Full text] [PDF]  

Focus Section
Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue

Hak Choy, Clinton Park, and Min Yao
Clin. Cancer Res. 2008; 14: 1633-1638. [Abstract] [Full text] [PDF]  

Focus Section
Proteasome Inhibitors in Cancer Therapy: Lessons from the First Decade

Robert Z. Orlowski and Deborah J. Kuhn
Clin. Cancer Res. 2008; 14: 1649-1657. [Abstract] [Full text] [PDF]  

Reviews
Is B-Raf a Good Therapeutic Target for Melanoma and Other Malignancies?

SubbaRao V. Madhunapantula and Gavin P. Robertson
Cancer Res. 2008; 68: 5-8. [Abstract] [Full text] [PDF]  

Reviews
Can Inhibiting Dihydropyrimidine Dehydrogenase Limit Hand-Foot Syndrome Caused by Fluoropyrimidines?

Jane L. Yen-Revollo, Richard M. Goldberg, and Howard L. McLeod
Clin. Cancer Res. 2008; 14: 8-13. [Abstract] [Full text] [PDF]  

CCR Focus
Toll-like Receptors in Tumor Immunotherapy

Chrystal M. Paulos, Andrew Kaiser, Claudia Wrzesinski, Christian S. Hinrichs, Lydie Cassard, Andrea Boni, Pawel Muranski, Luis Sanchez-Perez, Douglas C. Palmer, Zhiya Yu, Paul A. Antony, Luca Gattinoni, Steven A. Rosenberg, and Nicholas P. Restifo
Clin. Cancer Res. 2007; 13: 5280-5289. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5